No Data
No Data
William Blair Maintains Viking Therapeutics(VKTX.US) With Buy Rating
H.C. Wainwright Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $102
Express News | HC Wainwright & Co. Reiterates Buy on Viking Therapeutics, Maintains $102 Price Target
Viking Therapeutics Analyst Ratings
Positive Outlook for Viking Therapeutics: Strong Trial Enrollment and Upcoming Milestones Suggest Upside Potential
Express News | Viking Therapeutics Inc: Expects to Report Data From Study in Second Half of 2025.